Decitabine
Precancerous Condition
California Cancer ConsortiumSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
9 Active assets in the Precancerous Condition cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Epoetin Alfa Mayo Clinic | Phase 3 | BB |
Darbepoetin Alfa Mayo Clinic | Phase 3 | BB |
CYCLOSPORIN A Institut Paoli-Calmettes | Phase 2 | BB |
Cyclophosphamide Institut Paoli-Calmettes | Phase 2 | BB |
Selenium SWOG Cancer Research Network | Phase 3 | BB |
View all 50 →
Same molecule, other indications
Decitabine is also rated in:
acute myeloid leukemia with t(8;21)(q22;q22) translocationDormant
BB
Indicative ·
70 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →